Mark A. Hilfiker

524 total citations
12 papers, 308 citations indexed

About

Mark A. Hilfiker is a scholar working on Organic Chemistry, Pharmacology and Sensory Systems. According to data from OpenAlex, Mark A. Hilfiker has authored 12 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 4 papers in Pharmacology and 2 papers in Sensory Systems. Recurrent topics in Mark A. Hilfiker's work include Asymmetric Synthesis and Catalysis (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Asymmetric Hydrogenation and Catalysis (2 papers). Mark A. Hilfiker is often cited by papers focused on Asymmetric Synthesis and Catalysis (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Asymmetric Hydrogenation and Catalysis (2 papers). Mark A. Hilfiker collaborates with scholars based in United States and United Kingdom. Mark A. Hilfiker's co-authors include Scott G. Nelson, Andrew J. Kassick, Wing S. Cheung, Gabriela Zipp, Tram H. Hoang, Mui Cheung, Kevin S. Thorneloe, Hilary S. Eidam, Erin R. Mysak and Theresa J. Roethke and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Organic Chemistry and The Journal of Physical Chemistry A.

In The Last Decade

Mark A. Hilfiker

12 papers receiving 297 citations

Peers

Mark A. Hilfiker
Andrew Patron United States
David J. Rawson United Kingdom
Sze Kui Lam Hong Kong
Lamont R. Terrell United States
Edward J. Hutchinson United Kingdom
J.B.H. Warneck United Kingdom
Robert M. Rzasa United States
Manomi A. Tennakoon United States
David T. MacPherson United Kingdom
Andrew Patron United States
Mark A. Hilfiker
Citations per year, relative to Mark A. Hilfiker Mark A. Hilfiker (= 1×) peers Andrew Patron

Countries citing papers authored by Mark A. Hilfiker

Since Specialization
Citations

This map shows the geographic impact of Mark A. Hilfiker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Hilfiker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Hilfiker more than expected).

Fields of papers citing papers by Mark A. Hilfiker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Hilfiker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Hilfiker. The network helps show where Mark A. Hilfiker may publish in the future.

Co-authorship network of co-authors of Mark A. Hilfiker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Hilfiker. A scholar is included among the top collaborators of Mark A. Hilfiker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Hilfiker. Mark A. Hilfiker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Behm, David J., Hilary S. Eidam, Marlys Hammond, et al.. (2019). Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4). ACS Medicinal Chemistry Letters. 10(8). 1228–1233. 36 indexed citations
2.
Hilfiker, Mark A., Tram H. Hoang, Hilary S. Eidam, et al.. (2013). Optimization of a Novel Series of TRPV4 Antagonists with In Vivo Activity in a Model of Pulmonary Edema. ACS Medicinal Chemistry Letters. 4(2). 293–296. 19 indexed citations
3.
Hilfiker, Mark A., Patrick M. Eidam, Ning Wang, et al.. (2011). Structure–activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(10). 2806–2811. 6 indexed citations
4.
Hilfiker, Mark A., Ning Wang, Zhimin Du, et al.. (2009). Discovery of novel aminothiadiazole amides as selective EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(15). 4292–4295. 15 indexed citations
5.
Hilfiker, Mark A., Daohua Zhang, Sarah E. Dowdell, et al.. (2008). Aminomethylpiperazines as selective urotensin antagonists. Bioorganic & Medicinal Chemistry Letters. 18(16). 4470–4473. 13 indexed citations
6.
Zipp, Gabriela, Mark A. Hilfiker, & Scott G. Nelson. (2002). Enantioenriched Dihydropyrones from β-Lactone Templates. Organic Letters. 4(11). 1823–1826. 17 indexed citations
7.
Nelson, Scott G., Wing S. Cheung, Andrew J. Kassick, & Mark A. Hilfiker. (2002). A de Novo Enantioselective Total Synthesis of (−)-Laulimalide. Journal of the American Chemical Society. 124(46). 13654–13655. 75 indexed citations
9.
Nelson, Scott G. & Mark A. Hilfiker. (2000). ChemInform Abstract: Asymmetric Synthesis of Monodentate Phosphine Ligands Based on Chiral η6‐Cr[arene] Templates.. ChemInform. 31(4). 1 indexed citations
10.
Holden, Michael, et al.. (2000). In situ generation of (C5H5)Fe(C6H5O). Tetrahedron Letters. 41(33). 6275–6278. 6 indexed citations
11.
Nelson, Scott G. & Mark A. Hilfiker. (1999). Asymmetric Synthesis of Monodentate Phosphine Ligands Based on Chiral η6-Cr[arene] Templates. Organic Letters. 1(9). 1379–1382. 38 indexed citations
12.
Hilfiker, Mark A., et al.. (1997). Ligand-Modified Catalysts for the McMurry Pinacol Reaction. The Journal of Organic Chemistry. 62(14). 4566–4567. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026